mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.00089 |
1 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.00075 |
1 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.00094 |
1 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0005 |
1 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.00043 |
1 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.00037 |
1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00024 |
1 |